Search

Socioeconomic factors can influence the diagnosis and treatment of children in Texas with malignant solid tumors, increasing the risk of the cancer’s spread and lowering the five-year survival rate, according to researchers at UT Southwestern Medical Center.

UT Southwestern structural biologist and neuroscientist Ryan Hibbs, Ph.D., has received a 2022 Norman Hackerman Award in Chemical Research.

UT Southwestern researchers have identified vast webs of small snippets of the genome that interact with each other and with genes to promote prostate cancer.

A new treatment that combines two existing medications may provide long-sought relief for many battling debilitating methamphetamine use disorder, according to a study to be published tomorrow in The New England Journal of Medicine.

In recognition of outstanding teaching, the UT System’s Kenneth I. Shine, M.D., Academy of Health Science Education is inducting two UT Southwestern educators as new members during its annual conference in Austin.

A new nanoparticle-based drug can boost the body’s innate immune system and make it more effective at fighting off tumors, researchers at UT Southwestern have shown.

Traditional cardiovascular risk factors, such as blood pressure, cholesterol levels, diabetes, and smoking status, are at least as valuable in predicting who will develop coronary heart disease as a sophisticated genetic test that surveys millions of different points in DNA.

Daylight saving is approaching again, perhaps for the penultimate time in some countries where a fierce debate is being waged over its impact on health and the economy.

Dr. Beth Levine, UT Southwestern Professor of Internal Medicine and Microbiology, Director of the Center for Autophagy Research, and holder of the Charles Cameron Sprague Distinguished Chair in Biomedical Science, died Sunday after a battle with breast cancer.

A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center’s kidney cancer program.